Immunocore Holdings (IMCR) EPS (Basic) (2021 - 2026)
Immunocore Holdings (IMCR) posted EPS (Basic) of $0.26 for Q1 2026, up 142.8% sequentially from -$0.6 in Q4 2025, and up 156.83% YoY from $0.1 in Q1 2025.
Powered by 
Analysis
Immunocore Holdings (IMCR) EPS (Basic) (2021 - 2026) Analysis & Trends
Immunocore Holdings has reported EPS (Basic) for 6 years, with the latest figure at $0.26 in Q1 2026.
- Quarterly EPS (Basic) rose 156.83% year-over-year to $0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.54 (down 25.56% YoY) and the FY2025 annual result came in at -$0.71, up 30.97% from the prior year.
- EPS (Basic) advanced to $0.26 in Q1 2026 per IMCR's latest filing, from -$0.6 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.26 in Q1 2026 and troughed at -$0.65 in Q4 2022.
- A 5-year average of -$0.22 and a median of -$0.3 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 847.12% in 2024, then slumped 102.23% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.65 in 2022, then soared by 38.24% to -$0.4 in 2023, then slipped by 17.83% to -$0.48 in 2024, then decreased by 25.57% to -$0.6 in 2025, then jumped by 142.8% to $0.26 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $0.26, -$0.6, and -$0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Immunocore Holdings | 1.87 Bn | 989.25 Mn | 114.84 Mn | -0.02 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02 |
| Mar 31, 2026 | 0.26 |
| Dec 31, 2025 | -0.60 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.20 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | -0.48 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | -0.23 |
| Mar 31, 2024 | -0.49 |
| Dec 31, 2023 | -0.40 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.40 |
| Dec 31, 2022 | -0.65 |
| Sep 30, 2022 | 0.17 |
| Jun 30, 2022 | -0.46 |
| Dec 31, 2021 | -1.25 |
| Sep 30, 2021 | -1.57 |